Ekso Bionics (EKSO) Reports In-Line Q2 EPS

Ekso Bionics (NASDAQ: EKSO) reported Q2 EPS of ($0.13), in-line with the analyst estimate of ($0.13). Revenue for the quarter came in at $5 million versus the consensus estimate of $5.15 million.

For earnings history and earnings-related data on Ekso Bionics (EKSO) click here.

You May Also Be Interested In

• FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
• Cal-Maine Foods adds two independent directors, expanding board to ten
• Honeywell Aerospace to Join S&P 500 & S&P 100; Others to Join S&P MidCap 400 and S&P SmallCap 600